Related Experiment Video
Updated: Aug 9, 2025

07:17
Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
70.2K
Noncoding RNAs Controlling Oxidative Stress in Cancer
1Division of Experimental Cardiology, KU Leuven, 3000 Leuven, Belgium.
Cancers
|February 25, 2023
Summary
Noncoding RNAs regulate mitochondrial reactive oxygen species (ROS) and immune cell metabolism in cancer. Their complex roles in oxidative stress and intercellular communication highlight the need for further research in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Mitochondria in cancer cells produce excess reactive oxygen species (ROS), creating a cycle with genomic instability.
- Noncoding RNAs play a crucial role in regulating mitochondrial ROS and antioxidant expression within the tumor microenvironment.
- Immune cells, like cytotoxic T cells and macrophages, modulate ROS levels, influencing tumor growth and immune responses.
Purpose of the Study:
- To review the multifaceted roles of noncoding RNAs in regulating mitochondrial ROS production in cancer.
- To explore how noncoding RNAs influence the metabolic reprogramming of immune cells concerning ROS release.
- To examine the impact of noncoding RNA-containing microvesicles on intercellular communication and immune cell phenotypes in cancer.
Main Methods:
- Literature review focusing on noncoding RNAs, mitochondrial ROS, and cancer biology.
- Analysis of noncoding RNA regulation of antioxidant expression and immune cell metabolism.
- Investigation of microvesicle-mediated intercellular communication involving noncoding RNAs.
Main Results:
- Noncoding RNAs regulate mitochondrial ROS production and antioxidant expression, impacting the tumor microenvironment.
- Noncoding RNAs are involved in the metabolic reprogramming of immune cells, influencing their ROS release and function.
- Noncoding RNA-loaded microvesicles mediate cell-to-cell communication, potentially shifting immune cells towards a pro-oncogenic phenotype.
Conclusions:
- Noncoding RNAs exhibit complex, often opposing, effects on oxidative stress and tumor growth through various mechanisms.
- Interactions between noncoding RNAs and their shared functions suggest that targeting a single noncoding RNA may be insufficient.
- Further validation of noncoding RNA interactions across different cancer types and stages is essential for therapeutic development.
Related Concept Videos
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
Electron Transport Chain: Complex I and II
14.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
Types of RNA
6.0K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
RNA Stability
33.8K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.8K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K

